Established in 1987, the Washington University ACTU has been a highly productive participant in the AIDS Clinical Trials Group and is funded by the National Institute of Allergy and Infectious Diseases. Centrally located in the Midwest, it draws participants from Missouri, Illinois, Arkansas, Kansas, Tennessee, Nebraska and Oklahoma. Within the Division of Infectious Diseases, this ACTU is considered among the finest in the world. The Washington University ID-CRU is known for their expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to HIV and Infectious Disease research opportunities, community outreach and education.
Recently added to the ID-CRU is the HIV Prevention Trials Network PrEP program. Washington University is one of 28 US sites conducting this program and it is a first for the university and division. The overarching goal of the program focuses on providing new, innovative methods for increasing HIV preventive services for those at risk in the community. This combined community outreach, community engagement and biomedical intervention is a first of its kind. The ID-CRU is proud to host this program.
Team
Britanny Schneider
Clinical Research Coordinator, BS
- Phone: (314)273-1717
- Email: sbrittany@wustl.edu
Andrej Spec, MD, MSCI
Associate Professor of Medicine
- Phone: 314-454-8354
- Fax: 314-454-5392
- Email: aspec@wustl.edu
Dr. Spec‘s research is in fungal infections, particularly in immunocompromised patients, including those with transplants. His research focuses on Cryptococcus, Histoplasma, Candida, Aspergillus and other invasive molds. Dr. Spec also runs the division’s clinic focusing on invasive fungal infections, where he takes care of both immunocompromised and immunocompetent patients with fungal infections, which he considers the best and most rewarding part of his job.
